Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2006-09-19
2006-09-19
Richter, Johann (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C514S102000, C546S022000, C558S155000, C558S156000, C558S158000, C558S159000, C562S013000, C562S021000
Reexamination Certificate
active
07109184
ABSTRACT:
Disclosed is a phosphate transport inhibiting compound represented by Structural Formula (I):R1 and R2 are independently —H, an electron withdrawing group or a C1–C10alkyl group.Y is a covalent bond, a substituted methylene group, an unsubstituted methylene group or —CR1R2P(O)(OH)—.R3 is a hydrocarbyl group optionally comprising one or more amine, ammonium, ether, thioether or phenylene linking groups, a substituted hydrocarbyl group optionally comprising one or more amine, ammonium, ether, thioether or phenylene linking groups, a heteroaryl group, a substituted heteroaryl group or a phenyl group substituted with one or more groups selected from —Cl, —Br, —F, —CN, —NO2, —ORa, —N(Ra)2, —COORa, —CON(Ra)2, —CORa, —S(O)Ra, —S(O)2Ra, —S(O)2N(Ra)2, —NRaS(O)2Ra, —NRaCORa, a halogenated lower alkyl group, an aryl group, a substituted aryl group, or a halogenated alkoxy group.Each Rais independently —H, lower alkyl, substituted lower alkyl, aryl or substituted aryl.Each Rb is independently —H, a lower alkyl group, or a phosphate protecting group.
REFERENCES:
patent: 3632634 (1972-01-01), Maier
patent: 3845169 (1974-10-01), Maier et al.
patent: 4806532 (1989-02-01), Dousa
patent: 5496545 (1996-03-01), Holmes-Farley et al.
patent: 5574024 (1996-11-01), Ebetino
patent: 5667775 (1997-09-01), Holmes-Farley et al.
patent: 6083495 (2000-07-01), Holmes-Farley et al.
patent: 0 401 705 (1990-12-01), None
patent: 0 570 706 (1993-11-01), None
patent: 2 227 663 (1990-08-01), None
patent: WO 94/20508 (1994-09-01), None
Journal of Medicinal Chemistry,1995, 38, 1005-1014.
Magnin, D.R., et al., “1,1-Bisphosphonate Squalene Synthase Inhibitors: Interplay Between the Isoprenoid Subunit and the Diphosphate Surrogate,”J. Med. Chem., 38: 2596-2605 (1995).
McKenna, C.E., et al., “α-Halo [(Phenylphosphinyl)methyl]phosphonates as Specific Inhibitors of Na+-Gradient-Dependent Na+-Phosphate Cotransport Across Renal Brush Border Membrane,”J. Med. Chem., 35: 4885-4892 (1992).
Ebetino, F.H., et al., “Recent Works on The Synthesis of Phosphonate-Containing, Bone-Active Heterocylces,”Heterocycles, 30(2): 855-862 (1990).
Kelley, J.L., et al., “[[(Guaninylalkyl)phosphinico]methyl]phosphonic Acids. Multisubstrate Analogue Inhibitors of Human Erythrocyte Purine Nucleoside Phosphorylase,”J. Med. Chem., 38:1005-1014 (1995).
Stowell, M.H.B., et al., “The Phosphonylphosphinyl Dianion: A Convenient Synthon For The Preparation Of Biologically Interesting Phosphonylphosphinyl (P-C-P-C-) Compounds,”Tetrahedron Lett., 30(4):411-414 (1989).
Biller, S.A., and Forster, C., “The Synthesis of Isoprenoid (Phosphinylmethyl) Phosphonates,”Tetrahedron, 46(19): 6645-6658 (1990).
Biller, S.A., et al., “Isoprenoid (Phosphinylmethyl) Phosphonates as Inhibitors of Squalene Synthetase,”J. Med. Chem.31(10): 1869-1871 (1988).
Flohr, A., et al., “α-Functionalized Phosphonylphosphinates: Synthesis and Evaluations as Transcarbamoylase Inhibitors,”J. Med. Chem., 42: 2633-2640 (1999).
McClard, R. W., et al., “Novel Phosphonylphosphinyl (P-C-P-C) Analogues of Biochemically Interesting Diphosphates. Syntheses and Properties of P-C-P-C Analogues of Isopentenyl Diphosphate and Dimethylallyl Diphosphate,”J. Am. Chem. Soc. 109: 5544-5545 (1987).
Lindell, S. D., and Turner, R. M., “Synthesis of Potential Inhibitors of the Enzyme Aspartate Transcarbamoylase,”Tetrahedron Lett., 31(37): 5381-5384 (1990).
Ebetino, Frank H., et al., “Recent Work on the Synthesis of Phosphonate-Containing, Bone-Active Heterocycles,”Heterocylces, 30(2): 855-862 (1990).
Hilfiker, Helene, et al., “Characterization of a Murine Type II Sodium-Phosphate Cotransporter Expresed in Mammalian Small Intestine,”Proc. Natl. Acad. Sci. USA, 95: 14564-14569 (1998).
Ullrich, K. J., “Renal Transporters for Organic Anions and Organic Cations. Structural Requirements for Substrates,”J. Membrane Biol., 158: 95-107 (1997).
Loghman-Adham, M., et al., “Inhibition of Na+-PiCotransporter in Small Gut Brush Border by Phosphonocarboxylic Acids.” InAm. J. Physiol. 252: G245-G249 (1987).
Loghman-Adham, M., “Use of Phosphonocarboxylic Acids as Inhibitors of Sodium-Phosphate Cotransport,”Gen. Pharmac. 27(2): 305-312 (1996).
Rassier, M.E., et al., “A Novel Specific Inhibitor and Probe of Na+-PiCotransporter of Renal Cortical Brush Border Membrane Vesicles (BBMV),”J. Am. Soc. Nephrol., 1(4): 581 (1990).
McKenna, C.E., et al., “Synthesis and HIV-1 Reverse Transcriptase Inhibition Activity of Functionalized Pyrophosphate Analogues,”Phosphorous, Sulfur, and Silicon, 76: 139-142 (1993).
Maynard, H.D., et al., “Synthesis of Norbornenyl Polymers with Bioactive Oliogpeptides by Ring-Opening Metathesis Polymerization,”Macromolecules, 33(17): 6239-6248 (2000).
Bielawski, C.W., et al., “Highly Efficient Ring-Opening Metathesis Polymerization (ROMP) Using New Ruthenium Catalysis Containing N-Heterocyclic Carbene Ligands,”Angew. Chem. Int. Ed., 39(16): 2903-2906 (2000).
Sundell, M.J., et al., “Synthesis and Use as a Catalyst of Porous Polystyrene with Bis(phosphonic acid)-Functionalized Surfaces1,”Chem. Mater. 5: 372-376 (1993).
Sundell, M.J., et al., “Preparation of Poly[ethylene-g-(vinylbenzyl chloride)] and Functionalization with Bis(phosphonic acid) Derivatives,”Reactive Polymers 25: 1-16 (1995).
Ullrich, K.J., et al., “Interaction of Alkyl/Arylphosphonates, Phosphonocarboxylates and Diphosphonates with Different Anion Transport Systems in the Proximal Renal Tubule,”J. Pharmacol. Exp. Ther. 283(3): 1223-1229 (1997).
Szczepanska-Konkel, M., et al., “Structural Requirement of Monophosphates for Inhibition of Na+-PiCotransport in Renal Brush Border Membrane,”Biochem. Pharmacol. 38(23): 4191-4197 (1989).
Bastos Cecilia M.
Huval Chad C.
Jozefiak Thomas H.
Genzyme Corporation
Hamilton Brook Smith & Reynolds P.C.
Nwaonicha Chukwuma
Richter Johann
LandOfFree
Phosphate transport inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phosphate transport inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphate transport inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3620469